A company developing implants that release cell therapies is collaborating with a producer of regenerative stem cells to dispense insulin for people with diabetes. . . . → Read More: Companies Partner on Implanted Diabetes Beta Cell Device
|
|||||
       
 |
Early results from a clinical trial show an experimental gene transfer therapy largely reduces painful events from sickle cell disease for one to two years. . . . → Read More: Trial Shows Gene Therapy Results with Sickle Cell Disease 
A drug discovery company with an electronic screening process based on semiconductor technology is starting up and raising $9.25 million in seed funds. . . . → Read More: Semiconductor Tech Drug Discovery Company Underway  One comment - (Comments are closed)  Finance, New products  biomedical, chemistry, computer science, engineering, entrepreneurs, equity, investment, licensing, life sciences, nanotechnology, pharmaceuticals, physical sciences, physics, preclinical, semiconductors, university, venture capital 
Lab studies show an experimental synthetic antibody protects animals and neutralizes all SARS-CoV-2 variants of concern, including omicron BA.2. . . . → Read More: Preclinical Tests Show Antibody Stops Covid-19 Variants One comment - (Comments are closed) New products biomedical, biotechnology, Covid-19, entrepreneurs, Europe, licensing, life sciences, pharmaceuticals, venture capital 
A study with a small chip device simulating human lung functions shows normal breathing generates immune responses that protect against respiratory diseases. . . . → Read More: Lung Chip Reveals Respiratory Immune Responses Comments are closed New products biomedical, Covid-19, engineering, licensing, life sciences, medical device, pharmaceuticals, preclinical, university 
A company developing a needle patch for vaccine delivery is acquiring the rights to a synthetic SARS-Cov-2 spike protein for its Covid-19 vaccine patch. . . . → Read More: Univ. Lab Licenses Protein for Vaccine Patch Comments are closed Intellectual property, New products biomedical, biotechnology, chemistry, clinical trials, Covid-19, engineering, licensing, life sciences, medical device, pharmaceuticals, physical sciences, preclinical, university 
A biotechnology company discovering protein therapies in fungi is collaborating with drug maker GlaxoSmithKline to find new small molecule drugs. . . . → Read More: Drug Discovery Biotech Inks Partnering Deal, Gains $175M 3 comments - (Comments are closed) Finance, Intellectual property biomedical, biotechnology, cancer, chemistry, entrepreneurs, equity, genomics, licensing, life sciences, mathematics, pharmaceuticals, physical sciences, preclinical, university, venture capital 
A biotechnology enterprise plans to discover synthetic antibodies with 3-D printed lymph node tissue for future licensing to a pharma company. . . . → Read More: Synthetic Antibodies to be Designed with Organoids 
Tests with lab animals show a vaccine given as a nasal spray produces high antibody volumes against SARS-CoV-2 infections and reduces viral loads. . . . → Read More: Covid-19 Nasal Vaccine Produces Antibodies, Cuts Viral Load One comment - (Comments are closed) Joint ventures/collaborations, New products biomedical, biotechnology, Canada, Covid-19, licensing, life sciences, NIH, pharmaceuticals, preclinical 
A drug maker acquired commercialization rights to an injectable hydrogel developed at a university lab that delivers proteins to repair diseased tissue. . . . → Read More: Pharma Company Licenses Protein Delivery Hydrogel Comments are closed Intellectual property, New products Asia, biomedical, chemistry, engineering, India, licensing, life sciences, materials science, pharmaceuticals, physical sciences, university |
|
|||
|
Copyright © 2022 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
